896 related articles for article (PubMed ID: 38017433)
1. Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy.
Chehelgerdi M; Behdarvand Dehkordi F; Chehelgerdi M; Kabiri H; Salehian-Dehkordi H; Abdolvand M; Salmanizadeh S; Rashidi M; Niazmand A; Ahmadi S; Feizbakhshan S; Kabiri S; Vatandoost N; Ranjbarnejad T
Mol Cancer; 2023 Nov; 22(1):189. PubMed ID: 38017433
[TBL] [Abstract][Full Text] [Related]
2. Induced pluripotent stem cell consensus genes: implication for the risk of tumorigenesis and cancers in induced pluripotent stem cell therapy.
Zhang G; Shang B; Yang P; Cao Z; Pan Y; Zhou Q
Stem Cells Dev; 2012 Apr; 21(6):955-64. PubMed ID: 22185567
[TBL] [Abstract][Full Text] [Related]
3. Cancer cells as a new source of induced pluripotent stem cells.
Shamsian A; Sahebnasagh R; Norouzy A; Hussein SH; Ghahremani MH; Azizi Z
Stem Cell Res Ther; 2022 Sep; 13(1):459. PubMed ID: 36064437
[TBL] [Abstract][Full Text] [Related]
4. Induced pluripotency and oncogenic transformation are related processes.
Riggs JW; Barrilleaux BL; Varlakhanova N; Bush KM; Chan V; Knoepfler PS
Stem Cells Dev; 2013 Jan; 22(1):37-50. PubMed ID: 22998387
[TBL] [Abstract][Full Text] [Related]
5. Possible Strategies to Reduce the Tumorigenic Risk of Reprogrammed Normal and Cancer Cells.
Lin YC; Ku CC; Wuputra K; Liu CJ; Wu DC; Satou M; Mitsui Y; Saito S; Yokoyama KK
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791215
[TBL] [Abstract][Full Text] [Related]
6. Patient-derived induced pluripotent stem cells for models of cancer and cancer stem cell research.
Chao HM; Chern E
J Formos Med Assoc; 2018 Dec; 117(12):1046-1057. PubMed ID: 30172452
[TBL] [Abstract][Full Text] [Related]
7. Redox and Epigenetics in Human Pluripotent Stem Cells Differentiation.
Giallongo S; Rehakova D; Raffaele M; Lo Re O; Koutna I; Vinciguerra M
Antioxid Redox Signal; 2021 Feb; 34(4):335-349. PubMed ID: 32567336
[No Abstract] [Full Text] [Related]
8. Tumorigenic and Immunogenic Properties of Induced Pluripotent Stem Cells: a Promising Cancer Vaccine.
Qiao Y; Agboola OS; Hu X; Wu Y; Lei L
Stem Cell Rev Rep; 2020 Dec; 16(6):1049-1061. PubMed ID: 32939647
[TBL] [Abstract][Full Text] [Related]
9. Interconversion of Cancer Cells and Induced Pluripotent Stem Cells.
Sarker DB; Xue Y; Mahmud F; Jocelyn JA; Sang QA
Cells; 2024 Jan; 13(2):. PubMed ID: 38247819
[TBL] [Abstract][Full Text] [Related]
10. The miR-302-Mediated Induction of Pluripotent Stem Cells (iPSC): Multiple Synergistic Reprogramming Mechanisms.
Ying SY; Fang W; Lin SL
Methods Mol Biol; 2018; 1733():283-304. PubMed ID: 29435941
[TBL] [Abstract][Full Text] [Related]
11. Induced Pluripotent Stem Cells (iPSCs) in Developmental Toxicology.
Easley CA
Methods Mol Biol; 2019; 1965():19-34. PubMed ID: 31069666
[TBL] [Abstract][Full Text] [Related]
12. Induced pluripotent stem cell modeling of malignant hematopoiesis.
Chao MP; Majeti R
Exp Hematol; 2019 Mar; 71():68-76. PubMed ID: 30659850
[TBL] [Abstract][Full Text] [Related]
13. Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association.
Musunuru K; Sheikh F; Gupta RM; Houser SR; Maher KO; Milan DJ; Terzic A; Wu JC;
Circ Genom Precis Med; 2018 Jan; 11(1):e000043. PubMed ID: 29874173
[TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cells and their implication for regenerative medicine.
Csobonyeiova M; Polak S; Koller J; Danisovic L
Cell Tissue Bank; 2015 Jun; 16(2):171-80. PubMed ID: 25037593
[TBL] [Abstract][Full Text] [Related]
15. Human induced pluripotent stem cells--from mechanisms to clinical applications.
Drews K; Jozefczuk J; Prigione A; Adjaye J
J Mol Med (Berl); 2012 Jul; 90(7):735-45. PubMed ID: 22643868
[TBL] [Abstract][Full Text] [Related]
16. Applications of induced pluripotent stem cell technologies in spinal cord injury.
Nagoshi N; Okano H
J Neurochem; 2017 Jun; 141(6):848-860. PubMed ID: 28199003
[TBL] [Abstract][Full Text] [Related]
17. Engineering considerations of iPSC-based personalized medicine.
Park S; Gwon Y; Khan SA; Jang KJ; Kim J
Biomater Res; 2023 Jul; 27(1):67. PubMed ID: 37420273
[TBL] [Abstract][Full Text] [Related]
18. Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications.
Yoshihara M; Hayashizaki Y; Murakawa Y
Stem Cell Rev Rep; 2017 Feb; 13(1):7-16. PubMed ID: 27592701
[TBL] [Abstract][Full Text] [Related]
19. Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells.
Griscelli F; Féraud O; Oudrhiri N; Gobbo E; Casal I; Chomel JC; Biéche I; Duvillard P; Opolon P; Turhan AG; Bennaceur-Griscelli A
Am J Pathol; 2012 May; 180(5):2084-96. PubMed ID: 22425713
[TBL] [Abstract][Full Text] [Related]
20. Induced pluripotent stem cells (iPSCs) derived from different cell sources and their potential for regenerative and personalized medicine.
Shtrichman R; Germanguz I; Itskovitz-Eldor J
Curr Mol Med; 2013 Jun; 13(5):792-805. PubMed ID: 23642060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
